Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

Sacituzumab govitecan improves quality of life and extends life for breast cancer patients compared to standard chemotherapy.

Topical ceramide treatment partially improves the skin condition in Jack Russell Terriers with a genetic skin disorder.

Medical castration in prostate cancer patients can increase the risk of serious heart rhythm problems, so it's important to monitor heart activity during treatment.

A 23-year-old man has a benign, non-progressive hair loss patch that doesn't respond to treatment but can be cosmetically treated.

The 1298CC genotype in RA patients leads to higher methotrexate toxicity, while the 1298AA genotype results in better treatment response.

The DQB1*03 allele is linked to higher alopecia areata risk in Italians.

The new fluoroquinolone effectively fights certain bacteria.

A deficiency in the TTC7A gene causes immune problems, gut issues, and hair loss.

The developed model can predict effective 5-alpha-reductase enzyme inhibitors.

The method accurately measures Tamsulosin and Finasteride in medication and is suitable for regular quality checks.

Phosphodiesterase inhibitors like tadalafil can reduce cell growth in BPH caused by CD8+ T cells in low androgen conditions.

Biosimilars lower costs but don't significantly improve access.

Atorvastatin reversed memory problems caused by cancer drug trastuzumab and improved its cancer-fighting abilities without causing hair loss.

Patients with alopecia areata on ritlecitinib responded well to tetanus and meningococcal vaccines.

Topical tofacitinib shows promise as a future treatment for alopecia areata.

t-Flavanone may help hair growth by reducing a specific protein's activity in skin cells.

JAGGED1 could help regenerate tissues for bone loss and heart damage if delivered correctly.

JAK inhibitors like baricitinib are a new FDA-approved treatment for alopecia areata, but safety data is incomplete.

A woman with a unique syndrome similar to TRPS has a genetic change near the TRPS1 gene, affecting its regulation.

A man with severe hair loss and skin disease regrew his hair with no side effects after taking tofacitinib.

Testosterone reduces knee movement, while flutamide and finasteride increase it.

A new mutation in the STING protein causes a range of symptoms and its severity may be affected by other genetic variations; treatment with a specific inhibitor showed improvement in one patient.

Early detection and biotin treatment improve outcomes for biotinidase deficiency.

Tofacitinib effectively regrew scalp hair in an 11-year-old girl with alopecia areata.

Baricitinib works better for alopecia areata in patients not previously treated with tofacitinib.

Tofacitinib can cause skin eruptions similar to palmoplantar pustulosis.

Different ligands change the shape of the TRPV3 ion channel in unique ways.

Isoallopregnanolone may be a safe and effective treatment for reducing tics in a mouse model of Tourette syndrome.

Rezpegaldesleukin shows promise for treating severe alopecia areata.

Baricitinib is effective and safe for long-term use in severe alopecia areata, improving hair regrowth and quality of life with few side effects.